What is Boston Scientific's SG&A?

Boston Scientific (BSX) reported SG&A of $1.78B in Q1 2026.

How has Boston Scientific's SG&A changed year-over-year?

Boston Scientific's SG&A increased by 11.5% year-over-year, from $1.6B to $1.78B.

What is the long-term trend for Boston Scientific's SG&A?

Over 4 years (2021 to 2025), Boston Scientific's SG&A has grown at a 12.1% compound annual growth rate (CAGR), from $4.36B to $6.89B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Boston Scientific BSX SG&A

SG&A at other companies

AbbottABT

$3.74B+22.2%

TFX

TeleflexTFX

$226.01M+47.8%

Johnson & JohnsonJNJ

$6.03B+18.0%

StrykerSYK

$2.28B-0.8%

HaemoneticsHAE

$120.93M+5.0%

CONMEDCNMD

$141.7M-4.8%

Other financials

Income statement

See full

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

See full

Cash & equivalents$850.0M+146%

Total debt$659.0M-94.1%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

See full

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.3%

Free cash flow$171.0M-51.7%

Valuation

See full

Market cap$65.7B-56.2%

P/E18.5×-55.6×

P/S3.2×-5.4×

Profitability

See full

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

FCF margin16.9%-0.3pp

Returns & leverage

See full

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Boston Scientific's SG&A?: Boston Scientific (BSX) reported SG&A of $1.78B in Q1 2026.
How has Boston Scientific's SG&A changed year-over-year?: Boston Scientific's SG&A increased by 11.5% year-over-year, from $1.6B to $1.78B.
What is the long-term trend for Boston Scientific's SG&A?: Over 4 years (2021 to 2025), Boston Scientific's SG&A has grown at a 12.1% compound annual growth rate (CAGR), from $4.36B to $6.89B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.